Rituximab in the treatment of refractory pulmonary sarcoidosis
Nadera Sweiss(University of Illinois Chicago), Robert P. Baughman(University of Cincinnati), Joe G. N. Garcia(Scripps Research Institute), Steven M. Dudek(Illinois College), Patricia W. Finn(Harvard University Press), Elyse E. Lower(University of Cincinnati), Mehdi Mirsaeidi(Jacksonville University), David L. Perkins(United States Fish and Wildlife Service)
Cited by 174
Related Papers
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503